ICU Medical, Inc.
ICU Medical, Inc.（ICUI）内幕交易
基于 SEC Form 4 的买入/卖出笔数、买卖比与情绪标签；可在本季度与近12个月之间切换；下方为季度图与交易明细。
SEC EDGAR · FMP · ICUI · 截至 2026年6月8日
活动摘要
买入笔数
4
P-Purchase only
卖出笔数
6
近12个月
买卖比
0.67
Buy/Sell (by trades)
整体情绪
ICU Medical, Inc.内部人在过去近12个月主要在卖出股份，卖出行为通常由预设的Rule 10b5-1计划驱动，不一定代表对公司的负面看法。
▸ 数据来源：SEC EDGAR · Form 3 & 4 · 买入仅计P-Purchase · 卖出仅计S-Sale
截至 2026年6月8日
ICUI 季度内部人买卖趋势
ICUI 内幕交易卖出 · ICUI 内幕交易买入 · 季度活动
Mobile shows last 4Q · Desktop shows full 8Q
▸ 数据来源：SEC EDGAR · Form 3 & 4 · 最近8季度
As of Jun 8, 2026
活跃内部人
近12个月交易最活跃 · ICUI CEO内幕交易
显示全部内部人 · 点击卡片过滤下方交易表
▸ 按reportingName聚合 · 近12月交易次数Top5 · 无额外API
近期内幕交易记录
ICUI 高管卖出股份 · ICUI 董事内幕交易 · SEC Form 4申报
横向滑动查看全部列
| 日期 | 内部人 | 类型 | 股数 | 总金额 | 申报 |
|---|---|---|---|---|---|
| May 22, 2026 | Woolson Daniel President | Sale | 2,123 | $281K | Form 4 |
| May 14, 2026 | Sanzone Virginia Ruth VP, General Counsel | Sale | 2,447 | $304K | Form 4 |
| May 13, 2026 | KENNEDY KOLLEEN T Director | Option | 1,254 | — | Form 4 |
| May 13, 2026 | KENNEDY KOLLEEN T Director | Award | 1,475 | — | Form 4 |
| May 13, 2026 | KENNEDY KOLLEEN T Director | Option | 1,254 | — | Form 4 |
| May 13, 2026 | Hernandez Laurie Director | Option | 1,254 | — | Form 4 |
| May 13, 2026 | Hernandez Laurie Director | Award | 1,475 | — | Form 4 |
| May 13, 2026 | Hernandez Laurie Director | Option | 1,254 | — | Form 4 |
| May 13, 2026 | FINNEY ELISHA W Director | Option | 1,254 | — | Form 4 |
| May 13, 2026 | FINNEY ELISHA W Director | Award | 1,475 | — | Form 4 |
| May 13, 2026 | FINNEY ELISHA W Director | Option | 1,254 | — | Form 4 |
| May 13, 2026 | Abbey Donald Director | Option | 1,254 | — | Form 4 |
| May 13, 2026 | Abbey Donald Director | Award | 1,475 | — | Form 4 |
| May 13, 2026 | Abbey Donald Director | Option | 1,254 | — | Form 4 |
| May 13, 2026 | Hoffmeister David F Director | Option | 1,254 | — | Form 4 |
| May 13, 2026 | Hoffmeister David F Director | Award | 1,475 | — | Form 4 |
| May 13, 2026 | Hoffmeister David F Director | Option | 1,254 | — | Form 4 |
| May 12, 2026 | Greenberg David C. Director | Option | 2,424 | $245K | Form 4 |
| May 13, 2026 | Greenberg David C. Director | Option | 1,254 | — | Form 4 |
| May 12, 2026 | Greenberg David C. Director | Sale | 2,424 | $298K | Form 4 |
| May 13, 2026 | Greenberg David C. Director | Award | 1,475 | — | Form 4 |
| May 13, 2026 | Greenberg David C. Director | Option | 1,254 | — | Form 4 |
| Mar 25, 2026 | Abbey Donald Director | Other | 704 | — | Form 4 |
| Mar 15, 2026 | Voigtlander Christian B. COO | Option | 11,400 | — | Form 4 |
| Mar 15, 2026 | Voigtlander Christian B. COO | Option | 3,248 | — | Form 4 |
⚡ = 金额≥$100万 · Award/Option价格显示— · 仅Form4 · 仅普通股
▸ 数据来源：SEC EDGAR · Form 4 申报 · ⚡ = 金额≥$100万 · Award/Option 价格显示 —
关于 ICUI 内幕交易
ICUI 内幕交易
ICU Medical, Inc.（ICUI）内幕交易数据来源于公司内部人（包括Sanzone Virginia Ruth (VP, General Counsel), Woolson Daniel (President), Sousa Ben (Chief Information Officer)）提交的SEC Form 4申报文件。过去12个月内，5位内部人向SEC提交了交易申报。ICUI内部人近期主要在卖出，这可能反映预设的10b5-1计划执行，而非方向性判断。
如需查看ICU Medical, Inc.机构持仓比例和内部人持股百分比，请访问持仓（Ownership）标签页 → Ownership tab →
常见问题
ICUI 内幕交易 · 5个问题ICU Medical, Inc.（ICUI）的内部人包括高管和董事，如Sanzone Virginia Ruth (VP, General Counsel), Woolson Daniel (President), Sousa Ben (Chief Information Officer)等。过去12个月内，5位内部人向SEC提交了Form 4交易申报。内部人须在交易日期后2个工作日内完成申报。
▸ 数据来源：FMP /stable/insider-trading/search · SEC EDGAR Form 3 & 4 · RSU归属不计入情绪 · As of Jun 8, 2026